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A randomised controlled trial of two methods of
delivering nasal continuous positive airway
pressure after extubation to infants weighing less
than 1000 g: binasal (Hudson) versus single nasal
prongs
P Davis, M Davies, B Faber
Abstract
Objectives—Primary: to determine
whether nasal continuous positive airway
pressure (CPAP) delivered through bi-
nasal prongs results in a greater pro-
portion of extremely low birthweight in-
fants being successfully extubated, after a
period of intermittent positive pressure
ventilation, than nasal CPAP delivered by
a single nasal prong. Secondary: to evalu-
ate the eVect of mode of delivery of nasal
CPAP after extubation on the need for
endotracheal reintubation, weight gain,
rates of feeding intolerance, sepsis, sus-
pected sepsis, cranial ultrasound abnor-
malities, retinopathy of prematurity,
chronic lung disease, and the duration of
assisted ventilation and care in the terti-
ary neonatal unit.
Design and setting—Randomised, con-
trolled, clinical trial conducted at the neo-
natal intensive care unit of the Royal
Women’s Hospital, Melbourne, Australia.
Patients—Infants of birth weight less than
1000 g, ventilated, requiring < 50% oxygen
and ventilator rate less than or equal to
20/minute, and considered by the clinical
management team to be ready for extuba-
tion.
Intervention—Infants were randomly al-
located to receive nasal CPAP delivered
through binasal (Hudson) prongs or a sin-
gle nasal prong.
Primary outcome measure—Failure of
extubation as defined by the following cri-
teria: (a) apnoea (more than one episode/
hour over a six hour period or one episode
requiring bag and mask ventilation); (b)
absolute increase in oxygen requirement
greater than 15% above that required
before extubation; (c) respiratory acidosis
(pH < 7.25 with PCO2 > 6.67 kPa).
Results—Ten of the 41 (24%) infants
randomised to binasal prongs reached
predetermined failure criteria compared
with 26 of the 46 (57%) infants randomised
to a single nasal prong (p = 0.005). Four of
17 (24%) infants of birth weight less than
800 g extubated to binasal prongs reached
failure criteria compared with 14 of 16
(88%) extubated to a single nasal prong
(p < 0.001). There were no significant dif-
ferences in any of the secondary out-
comes.
Conclusions—For extremely low birth-
weight infants ventilated using an endo-
tracheal tube, nasal CPAP delivered
through binasal (Hudson) prongs is more
eVective in preventing failure of extuba-
tion than that delivered through a single
nasal prong.
(Arch Dis Child Fetal Neonatal Ed 2001;85:F82–F85)
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Current management of extremely low birth
weight (ELBW) infants—that is, those of birth
weight less than 1000 g—often includes inser-
tion of an endotracheal tube, positive pressure
ventilation, and exogenous surfactant adminis-
tration. Although these treatments may be life
saving, prolonged ventilation is associated with
the development of chronic lung disease,
pulmonary and systemic infections, and dam-
age to the upper airways. Early removal of the
endotracheal tube is thought desirable. A
systematic review has shown that the use of
nasal continuous positive airway pressure
(CPAP) is eVective in preventing failure of
extubation when compared with headbox oxy-
gen.1 Meta-analysis of seven randomised trials
showed that rates of extubation failure for
infants randomised to nasal CPAP ranged from
22% to 52%, with a pooled estimate of 34%.1
Several methods of delivering nasal CPAP were
used in the studies in this systematic review but
there have been no published randomised trials
comparing extubation failure rates of one
method of CPAP delivery with another. We
conducted a prospective randomised trial to
determine whether CPAP delivered by binasal
(Hudson) prongs resulted in a greater pro-
portion of infants being successfully extubated,
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without unwanted side eVects, compared with
management with a single short nasal prong.
Methods
All babies (inborn and outborn) admitted to
the neonatal intensive care unit at the Royal
Women’s Hospital, Melbourne, Australia were
considered for participation in this trial.
Eligibility criteria were (a) birth weight less
than 1000 g, (b) endotracheal intubation for
any duration, (c) stable or improving respira-
tory status with a ventilator rate less than or
equal to 20/minute and an inspired oxygen
concentration of less than 50%, and (d)
considered by the clinical management team to
be ready for extubation. The mode of CPAP
delivery was randomly allocated (using a
random number table and sequentially num-
bered, sealed, opaque envelopes) after in-
formed parental consent had been obtained.
Infants were stratified by sex and birth weight
(< 800 g and 800–999 g). Variable block sizes
were used within each stratum.
All infants received a loading dose of
theophylline and were extubated from low rate
ventilation rather than endotracheal CPAP or
high frequency oscillation. The sealed envelope
was opened immediately before extubation and
infants were allocated to receive nasal CPAP
through either a single nasal prong or binasal
Hudson prongs. Single prong CPAP was
administered through a size 2.5 or 3.0 Portex
tube (Portex Ltd, Hyth, Kent, UK) inserted
2.5 cm into one nostril and connected to a
ventilator. Binasal CPAP was administered
through a Hudson infant nasal CPAP cannula
(Hudson Respiratory Care Inc, Temecula,
California, USA) (fig 1). Ventilator flow rates
were set at 6 litres/minute, and the CPAP level
was set at 7 cm water initially in both groups.
CPAP was decreased according to the infant’s
status to a level of 5 cm water before
discontinuation. In both groups concentrations
of inspired oxygen were adjusted to maintain
oxygen saturation levels at 90–95%. Analysis of
capillary or arterial blood gases was performed
six hours after extubation and then at least
daily for the week after extubation.
PRIMARY OUTCOME
Successful extubation was determined over the
seven days after removal of the endotracheal
tube. An infant was deemed to have failed if
any of the following were experienced:
x apnoea: minor (more than six episodes
requiring physical stimulation over a six hour
period) or major (one episode requiring bag
and mask ventilation);
x an absolute increase in oxygen concentration
of greater than 15% above that required
immediately before extubation;
x respiratory acidosis—pH < 7.25 with
PCO2 > 6.67 kPa.
SECONDARY OUTCOMES
Endotracheal reintubation after occurrence of
failure criteria was at the attending clinician’s
discretion and this event was measured as a
secondary outcome. Weight gain over the week
after extubation and over the period from extu-
bation to discharge from hospital were
measured. Feeding intolerance was defined as
the presence of a fourth hourly gastric aspirate
greater than 25% of the feed volume or
containing bile during the week after extuba-
tion. Sepsis was diagnosed on the basis of a
positive culture of blood, cerebrospinal fluid, or
bladder tap urine. Suspected sepsis was defined
as a culture negative episode, treated with at
least five days of antibiotics in conjunction with
an immature to total neutrophil ratio of greater
than 0.15. Cranial ultrasound examinations
were performed within the first three days of
life, on days 7 and 28, and then monthly until
discharge; cerebroventricular haemorrhage was
classified as described by Papile et al.2 Infants
were examined every two weeks by an experi-
enced ophthalmologist, and retinopathy of
prematurity classified according to the Inter-
national Classification of Retinopathy of Pre-
maturity.3 Chronic lung disease was deter-
mined by supplemental oxygen requirement at
28 days of age or 36 weeks corrected age. Other
secondary outcomes included the duration of
assisted ventilation and care in the tertiary
neonatal unit.
A sample size of 130 was chosen to provide a
power of 80% to detect a reduction in failure
rate from 50% to 25% with a two tailed p of
less than 0.05. Interim analyses by an external
data monitoring committee were planned after
enrolment of 43 and 87 patients. According to
the O’Brien Fleming procedure4, the p values
to stop the trial were < 0.0006 after one third
of the patients entered and < 0.015 after two
thirds. ÷2 analysis was used for comparison of
failure rates and other categorical patient vari-
ables. A two tailed Student’s t test and Mann-
Whitney U test were used for continuous data
as appropriate.
The research and ethics committees of the
Royal Women’s Hospital, Melbourne, Victoria,
Australia approved the study.
Results
From October 1997 through July 1999, 164
infants of birth weight less than 1000 g were
admitted to the neonatal intensive care unit. Of
these, 23 were never intubated, 27 died before
extubation, and four were transferred to other
hospitals because of bed shortages. Reasons for
non-enrolment of the remainder included con-
sent refusal by the parents (6) or neonatologist
(2) and accidental extubation before consent
had been sought (15). The remaining 87
infants were randomised to receive either bi-
nasal (41) or single (46) nasal prongs.
Figure 1 Hudsons prongs extending about 1 cm inside the
nose.
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There were no significant diVerences in the
baseline variables known to influence neonatal
outcome (table 1). Babies reached minimal
levels of ventilatory support and were extu-
bated at a median of 3 days of age (table 1).
An external data monitoring committee per-
formed the first planned interim analysis after
43 patients. This showed no significant diVer-
ence between the two groups using the O’Brien
Fleming criteria.4 However, the committee
recommended that enrolment be discontinued
after the second interim analysis when the p
value was 0.005 for the primary outcome
measure.
Infants randomised to binasal CPAP were
less likely to reach the failure criteria than those
allocated to single prong (table 2). Not all
infants reaching the preset failure criteria were
reintubated, and, although fewer infants in the
binasal group were reintubated (22% v 41%),
this result did not reach significance
(p = 0.089). Within prespecified birth weight
strata, failure and reintubation rates were less
in the binasal group. These results were statis-
tically significant only for infants < 800 g.
There was no significant diVerence in the
incidence of death or chronic lung disease at
either 28 days or 36 weeks of corrected age.
Likewise there were no diVerences in the rates
of cerebroventricular haemorrhage, periven-
tricular leucomalacia, retinopathy of prematu-
rity, sepsis, or feeding intolerance. Weight gain
was similar in both groups. There were no sig-
nificant diVerences in total duration of assisted
ventilation, duration of endotracheal intuba-
tion, or stay in the level 3 centre.
Discussion
Although a simpler and less invasive form of
assisted ventilation of the newborn, the intro-
duction of nasal CPAP followed that of
intermittent positive pressure ventilation. Gre-
gory et al5 first described two methods of deliv-
ery of CPAP in 1971 for the treatment of RDS:
through an endotracheal tube and through a
pressure chamber around the infant’s head.
Subsequently, delivery through a face mask6
and nasal tubes ending above the vocal cords
have more commonly been used to deliver
CPAP.7 Several forms of these tubes exist, some
long enough to end just above the epiglottis
(nasopharyngeal) and some only 1–2 cm inside
the nose. Short prongs may be single or binasal.
The Infant Flow Driver (IFD; Electro Medical
Equipment, Brighton, Sussex, UK) is a binasal
system commonly used in the United King-
dom. In contrast with other binasal systems, it
uses a “fluidic flip” mechanism, which is
claimed to lead to a more stable level of CPAP
being delivered throughout the respiratory
cycle. A two hour crossover study showed no
real diVerence between the oxygen require-
ments or cardiorespiratory variables of infants
managed with the IFD and those of infants
managed with a single prong CPAP tube.8
These findings were supported by a non-
randomised cohort study, which concluded
that the IFD oVered no short term advantage
over single nasal prong CPAP.9 We could find
no randomised trials comparing diVerent
CPAP delivery devices that reported appropri-
ate long term outcomes. Single short prong
CPAP had been used for more than 10 years at
our centre. Our choice of an alternative CPAP
device was influenced by cohort studies
reporting the successful use of Hudson prongs
in other units.10
This study shows that binasal (Hudson)
prongs are more eVective in preventing extuba-
tion failure of ELBW infants than single short
nasal prongs. Specific failure criteria (apnoea,
respiratory acidosis, and increased oxygen
requirements) were chosen as the primary out-
come, rather than the other clinically important
outcome of endotracheal reintubation, to
reduce bias. A randomised trial of these
interventions could not be blinded. The
decision to reintubate an infant is subjected to
potential bias on the part of the clinician mak-
ing the decision; for example, a clinician with a
strong preference for one CPAP device may
persist with that device rather than reintubate
but elect for earlier intubation if the infant was
receiving the other form of CPAP. The
outcomes documented on an infant’s observa-
tion sheet allowed a more objective assessment
of an infant’s performance to be obtained.
Table 1 Patient characteristics
Binasal (n=41) Single (n=46)
Birth weight (g)* 790 (140) 816 (125)
Gestational age (weeks)* 26 (1.9) 26 (1.9)
Age at extubation (days)† 3 (1–9) 3 (1–6)
Inborn/outborn 37/4 37/9
Male/female 21/20 24/22
Single/multiple 32/9 31/15
Any maternal steroids 40 (98%) 44 (96%)
Surfactant‡ 39 (95%) 43 (93%)
Inspired oxygen concentration (%) at extubation† 21 (21–21) 21 (21–25)
Rate at extubation (breaths/minute)† 20 (15–20) 20 (15–20)
Mean airway pressure at extubation (cm H2O)† 6 (6–7) 6 (6–7)
*Mean (SD).
†Median (interquartile range).
‡Survanta (Ross Laboratories, Columbus, Ohio, USA).
Table 2 Primary and secondary outcomes of the use of binasal and single nasal prongs for
delivery of continuous positive airway pressure
Binasal (n=41) Single (n=46) p Value
Failure*
All 10 (24) 26 (57) 0.005
<800 g 4/17 (24) 14/16 (88) <0.001
800–999 g 6/24 (25) 12/30 (40) 0.384
Endotracheal reintubation*
All 9 (22) 19 (41) 0.089
<800 g 3/17 (18) 10/16 (63) 0.023
800–999 g 6/24 (25) 9/30 (30) 0.919
Death 3 (7) 2 (4) 0.895
Death or in O2 at 28 days 25 (61) 33 (72) 0.404
Death or in O2 at 36 weeks 20 (49) 28 (61) 0.360
Grade 3 or 4 IVH 3 (7) 2 (4) 0.895
PVL 0/40 (0) 3/46 (7) 0.291
Any ROP 25/38 (66) 26/45 (58) 0.602
Grade 3, 4, or 5 ROP 8/38 (21) 13/45 (29) 0.572
Sepsis 20 (49) 22 (48) 1.000
Suspected sepsis 19 (46) 23 (50) 0.900
Feeding intolerance* 19 (46) 17 (37) 0.503
Weight gain extubation to discharge (g/day)† 21 (7) 20 (6) 0.442
Days on IPPV/HFO/NCPAP‡ 35 (18–65) 45 (29–69) 0.276
Days on IPPV/HFO‡ 8 (2–23) 13 (3–27) 0.412
Days at level 3 centre‡ 76 (47–107) 73 (49–102) 0.902
Unless otherwise indicated, data are expressed as n (percentage). p Values in bold are significant.
*During week after extubation.
†Mean (SD).
‡Median (interquartile range).
IVH, Intraventricular haemorrhage; PVL, periventricular leucomalacia; ROP, retinopathy of
prematurity; IPPV, intermittent positive pressure ventilation; HFO, high frequency oscillation;
NCPAP, nasal continuous positive airway pressure.
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In a previous trial comparing single prong
CPAP with headbox oxygen for care after extu-
bation, we found a high rate of failure of extu-
bation (91%) in infants of birth weight below
800 g randomised to CPAP, and no advantage
of CPAP over a headbox in this subgroup.11
Stratification by birth weight was performed in
the present study to ensure balance between
the groups for this important prognostic
variable. Subanalysis on the basis of birth
weight showed an advantage for binasal prongs
in both strata but a statistically significant
diVerence in the lighter infants only.
For the study group as a whole and for the
stratum of heavier infants, a trend favouring
binasal prongs was seen for the outcome of
reintubation. This approached but did not
reach significance (p = 0.089). A significant
result favouring binasal prongs was seen in the
stratum of lighter infants. There appears to be
a clear message in the high failure rates seen in
the smallest babies randomised to single prong
CPAP in both studies. It is likely that these
infants with their lower respiratory reserves are
the most sensitive detectors of a treatment
eVect. The reasons for the superiority of the
binasal prongs are unclear. It is possible that
sealing both nostrils results in better transmis-
sion of pressure to the upper airways and the
lungs.
There were no indications from the other
secondary outcomes that the benefits of binasal
prongs were accompanied by unwanted side
eVects.
This study is only one of a number of com-
parisons of CPAP delivery devices possible. A
variety of single and double prong and
nasopharyngeal devices have been used. Fur-
ther randomised trials are required to deter-
mine which is superior. It is likely that
improvements in the design of CPAP devices
will occur that will refine CPAP administration
and make it more comfortable for infants.
Binasal Hudson prongs are an appropriate
benchmark against which newly developed
CPAP interfaces may be compared.
CONCLUSION
For ELBW infants ventilated using an endotra-
cheal tube, nasal CPAP delivered through
binasal (Hudson) prongs is more eVective in
preventing failure of extubation than that
delivered through a single nasal prong.
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